Electrical storm in an acquired short QT syndrome successfully treated with quinidine
Abstract Short QT syndrome (SQTS) is a malignant heart disorder defined by the presence of ventricular arrhythmias causing syncope and sudden cardiac arrest. The prevalence in the pediatric population is 0.05%. Quinidine is an established agent for pharmacological prophylaxis in SQTS patients, but c...
Main Authors: | Michael Spartalis, Efthimios Livanis, Eleftherios Spartalis, Alexandros Tsoutsinos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2282 |
Similar Items
-
Quinidine: an “Endangered Species” Drug Appropriate for Management of Electrical Storm in Brugada Syndrome
by: Stelios Paraskevaidis, MD, PhD, et al.
Published: (2013-09-01) -
The case for quinidine: Management of electrical storm in refractory ventricular fibrillation
by: Rebecca Pinnelas, MD, et al.
Published: (2020-07-01) -
Quinidine for Brugada syndrome: Panacea or poison?
by: Jo-Jo Hai, MBBS, et al.
Published: (2016-11-01) -
The inotropic effects of quinidine and procaine amide : an experimental study
by: Hastings, Elliot P.
Published: (2018) -
Electrophysiological mechanisms of long and short QT syndromes
by: Gary Tse, et al.
Published: (2017-03-01)